Roche NimbleGen, Inc., a subsidiary of Roche Diagnostics, is a leading player in the biotechnology industry, headquartered in the United States. Founded in 2000, the company has established itself as a pioneer in the development of advanced genomic solutions, particularly in the fields of microarray technology and next-generation sequencing. With a focus on high-resolution genomic analysis, Roche NimbleGen offers a range of core products, including custom microarrays and innovative sequencing solutions. These products are distinguished by their exceptional sensitivity and specificity, catering to researchers in genomics, cancer research, and personalised medicine. Roche NimbleGen's commitment to innovation has positioned it as a trusted partner in the life sciences sector, contributing significantly to advancements in genetic research and diagnostics. The company continues to achieve notable milestones, reinforcing its reputation as a leader in genomic technologies.
We don't have data for Roche NimbleGen, Inc., but we can show you information about their parent organization instead.
View parent company